2023
Hepatopancreatobiliary malignancies: time to treatment matters
Kerekes D, Frey A, Bakkila B, Johnson C, Becher R, Billingsley K, Khan S. Hepatopancreatobiliary malignancies: time to treatment matters. Journal Of Gastrointestinal Oncology 2023, 0: 0-0. PMID: 37201090, PMCID: PMC10186552, DOI: 10.21037/jgo-22-1067.Peer-Reviewed Original ResearchTreatment initiationStage IHPB cancersStage I pancreatic cancerExtrahepatic bile duct cancerKaplan-Meier survival analysisHPB cancer patientsNational Cancer DatabaseRetrospective cohort studyBile duct cancerMedian treatment initiationHepatopancreatobiliary cancersMedian survivalCohort studyDuct cancerOverall survivalHispanic patientsEHBD cancerOncologic careBile ductCox regressionBlack raceCancer patientsDefinitive carePancreatic cancer
2013
Bile duct involvement portends poor prognosis in resected gallbladder carcinoma.
Eil R, Hansen P, Cassera M, Orloff S, Sheppard B, Diggs B, Billingsley K. Bile duct involvement portends poor prognosis in resected gallbladder carcinoma. Gastrointestinal Cancer Research : GCR 2013, 6: 101-5. PMID: 24147157, PMCID: PMC3782874.Peer-Reviewed Original ResearchDisease-specific survivalDisease-free survivalBile duct involvementGallbladder cancerDuct involvementMedian disease-free survivalResection of GBCResectable gallbladder cancerSubset of patientsLog-rank analysisAdjuvant therapyLN involvementPrognostic factorsCox regressionPoor prognosisRetrospective studyUnfavorable prognosisUnivariate analysisGallbladder carcinomaUnivariate associationsStudy populationHigh riskIntraoperative methodHigh mortalityMultivariate analysis